Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve unaudited Financial ....
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Thursday, February 12, 2026, at the company's registered office in Ahmedabad. The main agenda is to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Any other business items may also be taken up during the meeting. The trading window for dealing in company securities has been closed since January 1, 2026 and will reopen 48 hours after the results are publicly announced.
This is a routine regulatory announcement ahead of quarterly results. Investors should watch for the actual Q3 FY26 numbers on or after February 12, 2026; the trading window closure means insiders and connected persons cannot trade until results are out.